Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. EBITDA 2023–2025
Connect Biopharma Holdings Ltd. annual/quarterly ebitda history and growth rate from 2023 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Connect Biopharma Holdings Ltd. ebitda for the quarter ending March 31, 2026 was -19.4 M, a 72.46% increase year-over-year.
- Connect Biopharma Holdings Ltd. annual ebitda for 2025 was -57.4 M, a 163.26% increase from 2024.
- Connect Biopharma Holdings Ltd. annual ebitda for 2024 was -21.8 M, a 68.11% decrease from 2023.
- Connect Biopharma Holdings Ltd. annual ebitda for 2023 was -68.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Connect Biopharma Holdings Ltd. EBITDA — FAQ
Connect Biopharma Holdings Ltd. (CNTB) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNTB's ebitda history?
The chart and table above show Connect Biopharma Holdings Ltd.'s ebitda by year and by quarter, including the growth rate.